Epidemiology and Clinical Features of Human Coronavirus
Epidemiology and Clinical Features of Human Coronavirus
批准号:
7197226
负责人:
HELEN Keipp TALBOT
金额:
$7.66万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-02-01 至 2009-01-31
关键词:
AcuteAge-YearsAntigensArchivesBiological AssayBronchiolitisCaringCell LineChicagoChildChildhoodClinicClinicalClinical DataCollectionComorbidityCoronavirusDataDatabasesDetectionDiagnostic ProcedureDisease OutbreaksEpidemiologic StudiesEpidemiologyGene ProteinsGeneticGoalsHong KongHumanHuman Coronavirus OC43Human MetapneumovirusHuman VirusIncidenceInfectious AgentInfluenzaLower respiratory tract structureMeasles virusMedicalMedical SurveillanceMethodsMolecular Diagnostic TechniquesMorbidity - disease rateNasal Lavage FluidNetherlandsOutpatientsPatientsPneumoniaPrevalencePublishingPurposeResearch PersonnelRespiratory Tract DiseasesRespiratory Tract InfectionsRespiratory syncytial virusReverse Transcriptase Polymerase Chain ReactionSamplingSequence AnalysisSerologicalSerumSevere Acute Respiratory SyndromeSpecimenSyndromeTimeUpper respiratory tractVaccinesViralVirusbaseclinical epidemiologycohorthuman coronavirusinterestmortalitynovelparainfluenza viruspathogenrespiratorytoolvirus culturevirus geneticsyoung adult
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Human coronaviruses (HCoV) were initially identified as major causes of acute respiratory tract disease in the 1960's. The epidemiology of two HCoV, OC43 and 229E, was established using only serological methods, due to difficulty culturing the viruses. Three new HCoV have been described in the last three years [1-4]: severe acute respiratory syndrome coronavirus (SARS-CoV) [4], human coronavirus Netherlands (HCoV-NL) [1, 2], and human coronavirus Hong Kong (CoV-HKU1) [3]. Each of these new viruses has been described in association with lower respiratory tract illness (LRI). The discovery of these viruses has renewed interest into the previously known HCoV OC43 and 229E which were known to cause upper respiratory tract illness (URI). HCoV OC43 and 229E have also been associated with LRI like the newly discovered coronaviruses. However, there are no published large-scale epidemiologic studies of OC43 and 229E using highly sensitive molecular diagnostic methods. The objectives of this study are to define the prevalence and clinical illnesses associated with the new human coronavirus HCoV-NL and the prototypic HCoV, OC43 and 229E, over a 20-year period in a cohort of over 2,000 previously healthy outpatient children. We also will determine the genetic variability of these viruses by amplifying and sequencing the HCoV spike protein gene. The Vanderbilt Vaccine Clinic (WC) clinical database and sample archive provide us with the tools to accomplish these goals. The WC provided comprehensive medical care to a large cohort of outpatient children who routinely had surveillance cultures of respiratory secretions and serum samples obtained, thus thousands of nasal wash and serum specimens are available for study, along with robust, prospectively collected clinical data. This provides a unique opportunity to investigate the importance of emerging human pathogens. Our preliminary data using samples from the WC indicate that coronaviruses are a significant cause of respiratory tract infection in children with a spectrum of illness and morbidity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Determining Influenza Vaccine Effectiveness (DIVE)
-
批准号:10225281
-
项目类别:
-
资助金额:$53.4万
-
财政年份:2015
-
负责人:HELEN Keipp TALBOT
-
依托单位:
Hospital Admissions & Emergency Room Visits in Adults Associated with Influenza C
-
批准号:9252833
-
项目类别:
-
资助金额:$1.75万
-
财政年份:2015
-
负责人:HELEN Keipp TALBOT
-
依托单位:
Determining Influenza Vaccine Effectiveness (DIVE)
-
批准号:9515563
-
项目类别:
-
资助金额:$64.98万
-
财政年份:2015
-
负责人:HELEN Keipp TALBOT
-
依托单位:
Determining Influenza Vaccine Effectiveness (DIVE)
-
批准号:9353955
-
项目类别:
-
资助金额:$55.24万
-
财政年份:2015
-
负责人:HELEN Keipp TALBOT
-
依托单位:
Hospital Admissions & Emergency Room Visits in Adults Associated with Influenza C
-
批准号:8882708
-
项目类别:
-
资助金额:$7.85万
-
财政年份:2015
-
负责人:HELEN Keipp TALBOT
-
依托单位:
Determining Influenza Vaccine Effectiveness (DIVE)
-
批准号:9027552
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2015
-
负责人:HELEN Keipp TALBOT
-
依托单位:
Effectiveness of the Influenza Vaccine in the Aging Population
-
批准号:8417869
-
项目类别:
-
资助金额:$31.98万
-
财政年份:2013
-
负责人:HELEN Keipp TALBOT
-
依托单位:
Effectiveness of the Influenza Vaccine in the Aging Population
-
批准号:8676623
-
项目类别:
-
资助金额:$32.19万
-
财政年份:2013
-
负责人:HELEN Keipp TALBOT
-
依托单位:
Adult flu hospitalizations: evaulating diagnostic methods & vaccine effectiveness
-
批准号:7776967
-
项目类别:
-
资助金额:$12.55万
-
财政年份:2008
-
负责人:HELEN Keipp TALBOT
-
依托单位:
Adult flu hospitalizations: evaulating diagnostic methods & vaccine effectiveness
-
批准号:7571578
-
项目类别:
-
资助金额:$12.55万
-
财政年份:2008
-
负责人:HELEN Keipp TALBOT
-
依托单位:
Adult flu hospitalizations: evaulating diagnostic methods & vaccine effectiveness
-
批准号:7471749
-
项目类别:
-
资助金额:$12.55万
-
财政年份:2008
-
负责人:HELEN Keipp TALBOT
-
依托单位:
Adult flu hospitalizations: evaulating diagnostic methods & vaccine effectiveness
-
批准号:8035973
-
项目类别:
-
资助金额:$12.55万
-
财政年份:2008
-
负责人:HELEN Keipp TALBOT
-
依托单位:
海外基金